Retina Synthesis
Un pódcast de Retina Synthesis
147 Episodo
-
Biosimilar Drugs for Retinal Diseases
Publicado: 6/7/2023 -
Faricimab vs Aflibercept in Diabetic Macular Edema
Publicado: 29/6/2023 -
Artificial Intelligence in the Management of Geographic Atrophy
Publicado: 22/6/2023 -
Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma
Publicado: 15/6/2023 -
Faricimab in the Treatment of Retinal Venous Occlusion
Publicado: 8/6/2023 -
The Use of High Dose Aflibercept in Diabetic Macular Edema
Publicado: 1/6/2023 -
Widefield OCT Angiography
Publicado: 25/5/2023 -
Aflibercept Therapy of Retinopathy of Prematurity
Publicado: 18/5/2023 -
Home OCT in the Management of Neovascular AMD: Latest Development
Publicado: 11/5/2023 -
Suprachoroidal Corticosteroids for the Treatment of Macular Edema
Publicado: 4/5/2023 -
The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema
Publicado: 27/4/2023 -
Suprachoroidal Therapy of Neovascular AMD
Publicado: 20/4/2023 -
Microperimetry in the Assessment of Geographic Macular Atrophy
Publicado: 13/4/2023 -
Subretinal Gene Therapy for Neovascular AMD
Publicado: 6/4/2023 -
A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD
Publicado: 30/3/2023 -
15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD
Publicado: 23/3/2023 -
Dexamethasone Implant for Treating Diabetic Macular Edema
Publicado: 16/3/2023 -
Retinal Vasculitis Update
Publicado: 2/3/2023 -
Central Serous Chorioretinopathy
Publicado: 23/2/2023 -
Faricimab Update
Publicado: 16/2/2023
Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.
